Pure Rawz

What we read

For this preview profile we synthesized: approximately 90 r/Peptides comments mentioning Pure Rawz between December 2025 and April 2026; the vendor's published COAs on the GLP-1 SKUs (retatrutide, tirzepatide, semaglutide) and the healing-peptide flagships (BPC-157, TB-500); and Janoshik public-test entries where batch IDs were traceable. This is not a first-hand audit and does not include test orders we placed ourselves.

Why Pure Rawz sits where it does

Pure Rawz has been operating in the US-domestic research-peptide market for several years — long enough to predate the 2025 shutdown wave. It was not one of the most-recommended vendors at the top of the market (Peptide Sciences and Amino Asylum held that position through 2024), but it was consistently named as a stable secondary option: the vendor people moved to when they wanted variety, lower prices on specific SKUs, or a backup source.

The vendor profile that emerges from public data:

• US-domestic operation: ships within the US. Domestic shipping reports cluster around 3–5 days, slightly slower than the cycle's fastest US-domestic vendors but consistent.
• COA practices: vendor publishes third-party COAs on the GLP-1 flagships and on BPC-157 / TB-500. COA discipline on the long tail (less-popular research peptides) is reported by community sources as less consistent — some SKUs have published COAs, others do not.
• Catalog breadth: covers the GLP-1 mainstream plus an unusually wide tail of ancillary research compounds. This is part of the vendor's positioning — breadth, not flagship purity.
• Pricing: positioned on the lower side of the cycle median for the GLP-1 SKUs we tracked. Roughly 5–15% below mid-tier vendors on retatrutide and tirzepatide.

Community sentiment

The dominant theme in r/Peptides comments was stability, not excellence. Pure Rawz was rarely described as the best option for any single dimension — fastest shipping, cleanest COAs, lowest prices — but it was repeatedly named as the vendor that "consistently shipped what was ordered" with "no surprises" across multi-year ordering histories.

Secondary themes included:

• Pricing as the primary draw — multiple commenters cited Pure Rawz as the price-competitive option for stacked orders
• Customer service as the primary friction — reports of slow responses (24–72 hours) on edge-case inquiries; this lowered the community-derived support subscore relative to peers
• COA depth on niche SKUs — the long-tail catalog is where community confidence drops; flagship SKUs get higher confidence

The most-cited concern was inconsistency on the long tail. Buyers ordering the GLP-1 mainstream (retatrutide, tirzepatide, semaglutide) reported a different experience than buyers ordering less-common research peptides, where COA quality and packaging discipline were described as more variable.

What we'd verify in a full audit

When this profile graduates from public-data preview to full audit, the specific dimensions we'd test:

• Independent Janoshik HPLC + mass-spec on retatrutide and at least one long-tail SKU; cross-reference vendor-stated COA against our independent result within our 1.5-percentage-point tolerance — the long-tail check is the differentiator for this vendor specifically
• Three test orders placed under aliases through a US receiving address; median dispatch and transit time logged
• Customer-service response time tested with one realistic and one deliberately confusing inquiry, business hours; the community signal on slow responses is the specific claim our audit needs to verify
• Endotoxin and sterility verification on at least one batch

FAQ

Is Pure Rawz a US vendor? Yes, US-domestic with multi-year operating history under the same brand identity. Domestic transit averages 4 days.

What compounds does Pure Rawz carry? Broad catalog spanning research peptides (retatrutide, tirzepatide, semaglutide, BPC-157, TB-500) plus ancillary research compounds.

Does Pure Rawz publish lab tests? Yes. Third-party COAs are published on flagship SKUs with batch IDs. Long-tail SKUs are tested less rigorously than the mainstream. Verify test IDs at our COA verifier.

Has Pure Rawz had any regulatory action? No public regulatory action against the peptide catalog as of May 2026. We track FDA Warning Letter activity in our FDA peptide enforcement timeline.

Related

• Where to buy retatrutide in 2026
• How to verify a Janoshik COA
• FDA peptide enforcement, 2024-2026

• Janoshik public-tests database↗ — Janoshik Analytical
• Pure Rawz vendor stability ranking↗ — The Peptide Catalog
• Janoshik 7,164-tests purity analysis — vialaudit